Researchers are making strides in stem cell-based therapies, with trials underway for conditions ranging from Parkinson’s disease to heart attacks and degenerative eye diseases. At the University of Oslo, scientists are reprogramming skin cells into induced pluripotent stem cells (iPS cells), which can differentiate into various specialized cell types.
About the Author
